Guilin Layn Natural Ingredients Corp.: 2023 Annual Equity Distribution Implementation Notice
Guilin Layn Natural Ingredients Corp.: Announcement on the progress of providing guarantees to subsidiaries
Guilin Layn Natural Ingredients Corp.: 002166 RheinBio Investor Relations Management Information 20240511
Guilin Layn Natural Ingredients Corp.: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Guilin Layn Natural Ingredients Corp.: Announcement on the progress of the repurchase of company shares
Guilin Layn Natural Ingredients Corp.: Legal Opinions of Beijing Deheng Law Firm on the 2023 Annual General Meeting of Shareholders of Guilin Rhine Biotechnology Co., Ltd.
Guilin Layn Natural Ingredients Corp.: 002166 RheinBio Investor Relations Management Information 20240429
Guilin Layn Natural Ingredients Corp.: 002166 RheinBio Investor Relations Management Information 20240429
Guilin Layn Natural Ingredients Corp.: 2024 First Quarter Report
Guilin Layn Natural Ingredients Corp.: Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
Guilin Layn Natural Ingredients Corp.: Announcement on partial share pledges by controlling shareholders and actual controllers
RheinBio: Announcement on holding the 2023 online results briefing
RheinBio: 002166 RheinBio Investor Relations Management Information 20240416
RheinBio: 002166 RheinBio Investor Relations Management Information 20240411
RheinBio: Announcement on the forecast for daily related transactions in 2024
RheinBio: Annual Report 2023
RheinBio: 2023 Annual Report Summary
RheinBio: Report on the work of the Board of Directors for the year 2023
RheinBio: Report on the 2023 Assessment Report on the Performance of Accounting Firms
RheinBio: Opinions of Everbright Securities Co., Ltd. on the 2023 Internal Control Evaluation Report of Guilin Rhine Biotechnology Co., Ltd.
No Data